Sanofi Articles
Bayer initiates Ph III Stivarga study in liver cancer; Sanofi enrolls sarilumab patients
15 May 2013
Positive CHMP recommendations for Astellas Xtandi, Roche's Erivedge, as well MACI, Nuedexta and Spedra
28 April 2013
Court rules in novel False Claims Act case where one pharma firm sues another viewed by HP&M lawyer
28 April 2013
US FDA fast-track for Sanofi Pasteur's KB001A; orphan status for Teva/Xenon's XEN402; second BD Simplist product approved
23 April 2013
Merrimack presents encouraging preclinical research with MM-121 in ER-positive breast cancer model
11 April 2013
Sanofi broadens collaboration with Pieris
10 April 2013
BioTrends views Xeljanz and Zytiga prescribing in USA
26 March 2013
Brazil's CAPES joins forces with Sanofi to provide scholarship students with training in research centers abroad
25 March 2013
Sanofi and Transgene collaborate on immunotherapy treatments; NAS designation of Aubagio disputed
25 March 2013
US FDA accepts Sanofi's NDA for diabetes drug lixisenatide
19 February 2013
Sanofi eyes big plans for China
11 February 2013
Sanofi 4th-qtr earnings slump but still beat expectations; expects growth to resume in 2013
7 February 2013
Sanofi's once-daily diabetes drug Lyxumia approved in Europe
4 February 2013
Nanolek and Bilthoven Biologicals to start first production of inactivated polio vaccine in Russia
17 January 2013
Japan's seasonal flu vaccines market analysis
16 January 2013
News briefs from Sanofi, Bayer, GlaxoSmithKline and Novartis
21 December 2012
News briefs on Sanofi, Novo Nordisk and GlaxoSmithKline/Amicus
20 December 2012
News briefs: Lexicon's IBS drug; Sanofi Pasteur launch in Thailand; Tranzyme drops TZP-102
17 December 2012
Makers of Kynamro and Fanaptum to appeal negative CHMP opinions
17 December 2012
Australian launch for Sanofi Pasteur's Imojev, first single-dose vaccine against Japanese encephalitis
11 December 2012
FDA advisory gives thumbs down for Zogenix' Zohydro for chronic pain; EU label extension for Genzyme's Thyrogen
10 December 2012
Novartis' Gilenya MS patient share growth in Europe likely driven by improved product satisfaction and efficacy-related
9 December 2012
CREW files motion to quash Sanofi Pasteur subpoena
6 December 2012
Sanofi inks up to $900 million allergy pact with Selecta Biosciences
28 November 2012
Zealand Pharma valuation hinged on Lyxi/Lanti "fixflex"
23 November 2012
Sanofi MS drug Aubagio gets second approval, in Australia
21 November 2012
Senior appointments at Sanofi, Shire and Targacept; Global Fund names new executive director, fires inspector general
16 November 2012
Global diabetes drugs market led by Novo Nordisk and Sanofi
14 November 2012
News briefs from Genzyme, Sagent, Orchid and Kyowa Hakko
14 November 2012
Sanofi and Regeneron recruiting patients for cardiovascular outcomes trial with antibody to PCSK9 for hypercholesterolemia
5 November 2012
News briefs: Eli Lilly expands insulin facility; and Sanofi criticized over Lemtrada
2 November 2012
News briefs from Sanofi, Biogen/SOBI and Novartis
1 November 2012
Sanofi yet another to be hit by generic competition
26 October 2012
Alnylam gets upfront $22.5 million in RNAi link with Genzyme
23 October 2012
FDA advisory panel votes 9 to 6 to approve Genzyme's Kynamro
19 October 2012
Watson gets FDA approval for generic Sanctura XR and Avapro
14 October 2012
Positive Ph III VELOUR results with Sanofi's Zaltrap
10 October 2012
Sanofi buys Colombian drugmaker; Presents encouraging eliglustat and Lyxumia data; Revizes deal with B-MS
3 October 2012
News briefs: AstraZeneca suspends share repurchasing; New CMO for Sanofi; Research facility for Octapharma
2 October 2012
Osiris regains worldwide rights to Prochymal and Chondrogen from Sanofi
30 September 2012
US multiple sclerosis market growth remains centered on Tysabri and Gilenya ahead of Aubagio's launch
28 September 2012
Pharma vs the world: Big Pharma caught between investors and public
23 September 2012
Top drugmakers set up non-profit TransCelerate to speed pharma R&D
20 September 2012
Analyst insight: Sanofi eyes Columbia, Indonesia and Vietnam
20 September 2012
Oncodesign in up to 130 million-euro deal with Sanofi
14 September 2012
FDA thumbs up for Sanofi's MS drug Aubagio
13 September 2012
Clinical trial results indicate advance in Dengue vaccine research by Sanofi Pasteur
12 September 2012
Impax Labs settles with Genzyme over Renvela and Renagel generics
5 September 2012
New Zealand's PHARMAC agrees pricing deal with Sanofi for Arava
4 September 2012
Teva launches generic Aprovel in UK
30 August 2012
FDA calls on Genzyme to re-file Lemtrada sBLA
28 August 2012
US genericization of clopidogrel will initially contract ACS market, before uptake of novel oral agents lifts sector to $2.7 billion
27 August 2012
Sanofi moves on Lemtrada; Novartis Indian patent case
21 August 2012
Sanofi Pasteur's dengue vaccine proves effective and safe; FDA identifies cGMP deviations
25 July 2012
Vivalis in new EB66 cell line deal with Merial
18 July 2012
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Pfizer to split-off remaining 80% interest in Zoetis
